| Company/Division name | Biotrial S.A. |
| Parent company | Biotrial S.A. |
| Type of work | IT |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 60 |
| Year reshoring announced: | 2013 |
| Year reshoring implemented or to be implemented: | 2014 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | France |
| City reshored to: | Newark |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Other, Research/Services |
| Product(s) reshored | pharmaceutical testing |
| What non-domestic negative factors made offshoring less attractive? | Regulatory compliance |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Infrastructure, Skilled workforce availability/training |
